skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Human thyreoglobulin (HTG) for the diagnosis of recurrent differentiated thyroid carcinoma: Evaluation by ROC - analysis

Journal Article · · Journal of Nuclear Medicine
OSTI ID:441584
; ;  [1]
  1. Nuklearmedizinische Klinik und Poliklinik, Muenchen (Germany); and others

The value of hTg-measurements are still discussed controversially. Also, there are no tables with sensitivity/specificity pairs for different cutoffs, since valuable information is lost by presenting only one sensitivity/specificity pair. Therefore, we wanted to determine these values for hTg by a ROC-analysis. Inclusion criteria were: (a) differentiated thyroid carcinoma (papillary or follicular), (b) no thyroid-rest after primary therapy (e.g. no detectable hTg and nc iodine accumulating foci in iodine-whole body scan), (c) no detectable hTg- antibodies, (d) an observation period of at least 1 year, hTg was determined by TG-RIA and hTg-antibodies by IMMUtest anti-Tg. Recurrence was proven by iodine-whole-body scans under maximal endogenous TSH-stimulation or by histology. Sensitivity and specificity were calculated for different hTg-cutoffs. During 10/80 and 10/89 93 patients met these criteria. There were 71 female and 22 male with a mean age of 48.6 {plus_minus} 16.3 years. 51 patients had papillary carcinomas, 42 patients follicular carcinomas. The observation period was 78.4 {plus_minus} 40.9 months. In these 93 patients there were 16 recurrences during the observation period. Sensitivity/specificity pairs for different cutoffs are given. These sensitivity/specificity pairs avoid the reduction of the original continuous data to a Yes/No decision. The knowledge of these data and of the ROC-curve could improve the intuitive rating of a laboratory result by the physician.

OSTI ID:
441584
Report Number(s):
CONF-950603-; ISSN 0161-5505; TRN: 96:002093-0008
Journal Information:
Journal of Nuclear Medicine, Vol. 36, Issue Suppl.5; Conference: 42. annual meeting of the Society of Nuclear Medicine, Minneapolis, MN (United States), 12-15 Jun 1995; Other Information: PBD: May 1995
Country of Publication:
United States
Language:
English

Similar Records

Thyroglobulin levels to follow-up patients with treated differentiated thyroid carcinoma
Journal Article · Sun Jan 01 00:00:00 EST 1984 · Cancer Detect. Prev.; (United States) · OSTI ID:441584

Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
Journal Article · Tue Mar 01 00:00:00 EST 1988 · Cancer (Philadelphia); (United States) · OSTI ID:441584

Usefulness of thallium-201 imaging in the diagnosis of metastases from differentiated thyroid carcinoma
Conference · Sun Jan 01 00:00:00 EST 1984 · J. Nucl. Med.; (United States) · OSTI ID:441584